Begum Alaybeyoglu

Title: Begum Alaybeyoglu: Innovator in Neurodegenerative Research

Introduction

Begum Alaybeyoglu is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of neurodegenerative research through her innovative work. Her dedication to advancing medical science is evident in her patented inventions.

Latest Patents

Alaybeyoglu holds a patent for a neurodegenerative target discovery platform. This microphysiological system (MPS) includes at least one first inlet for receiving a fluid medium. The MPS comprises a brain module containing brain tissue and a blood-brain-barrier (BBB) module that includes BBB tissue, configured to receive the fluid medium. Additionally, the MPS features a crosstalk channel between the brain module and the BBB module, promoting bidirectional crosstalk between the brain tissue and the BBB tissue in response to the fluid medium. The MPS is designed for treating both the brain tissue and the BBB tissue with drugs to determine their phenotypic and transcriptomic effects. This innovative approach is related to drug perturbation based on kinetic optimization.

Career Highlights

Begum Alaybeyoglu is currently associated with Javelin Biotech, Inc., where she continues her research and development efforts. Her work is pivotal in understanding and treating neurodegenerative diseases, showcasing her commitment to improving patient outcomes.

Collaborations

Alaybeyoglu collaborates with notable colleagues, including John Wayne Rumsey and Murat Cirit. These partnerships enhance her research capabilities and contribute to the advancement of her projects.

Conclusion

Begum Alaybeyoglu is a trailblazer in the field of neurodegenerative research, with a focus on innovative solutions that can lead to significant medical advancements. Her contributions through her patent and collaborations reflect her dedication to improving healthcare.